Health

GoPath Obtains NY State License for its ProstateNow™ Genetic Test

Leave a comment


GoPath Logo

GoPath Diagnostics

“Our ProstateNow™ test approval in NY is a significant milestone in our growth as a company, enabling us to better serve healthcare providers and patients through our comprehensive suite of services.” – Dr. Jim Lu, CEO and Medical Director of GoPath Diagnostics.


CHICAGO (PRWEB)

GoPath Diagnostics, a leading innovative molecular diagnostic company, is proud to announce that they have recently earned a clinal laboratory license that grants authorization from the New York State Department of Health to perform its ProstateNow™ test, in addition to already approved, Histopathology and Oncology – Molecular and Cellular Tumor Markers testing. ProstateNow™ is a cutting-edge genetic test that helps individuals determine their risk of developing prostate cancer.

ProstateNow™ is the only germline test that includes both Rare Pathogenic Mutations (RPMs) & Genetic Risk Score (GRS) for a comprehensive assessment of inherited risk for prostate cancer. To learn more about this groundbreaking test, please visit the following website: https://geneticsnow.com/prostatenow

“We are very excited to have expanded our New York State License approval to now offer ProstateNow™, as it represents a significant milestone in our growth as a company,” says Dr. Jim Lu, CEO and Medical Director of GoPath Diagnostics. “This enhancement enables GoPath to better serve healthcare providers and patients in New York through our comprehensive suite of services, further bolstering our commitment to providing top-notch healthcare services.”

About GoPath Diagnostics

GoPath Diagnostics specializes in molecular, genetics, anatomic pathology, hematopathology, cytology, and digital pathology services. With advanced technologies and an experienced team of laboratory professionals, GoPath Diagnostics provides accurate, reliable, and timely test results to enable clinical healthcare providers to make informed treatment decisions and to empower pathologists by enhancing their molecular and digital capabilities.

For more information about GoPath Diagnostics and its laboratory testing services, please visit the company’s website at http://www.gopathdx.com

Share article on social media or email:

Leave a Reply